| Literature DB >> 35672747 |
Jade D Rae1,2,3, Suphak Nosten4, Ladda Kajeechiwa4, Jacher Wiladphaingern4, Daniel M Parker5,6, Jordi Landier7, Aung Myint Thu4, Hsa Dah4, Aye Be4, Win Cho Cho4, K 'Nyaw Paw4, Eh Shee Paw4, Paw Bway Shee4, Christ Poe4, Chit Nu4, Baw Nyaw4, Julie A Simpson8, Angela Devine8,9, Richard J Maude10,11,12,13, Ku Ler Moo4, Myo Chit Min4, May Myo Thwin4, Saw Win Tun4, François H Nosten4,11.
Abstract
BACKGROUND: The collection and utilization of surveillance data is essential in monitoring progress towards achieving malaria elimination, in the timely response to increases in malaria case numbers and in the assessment of programme functioning. This paper describes the surveillance activities used by the malaria elimination task force (METF) programme which operates in eastern Myanmar, and provides an analysis of data collected from weekly surveillance, case investigations, and monitoring and evaluation of programme performance.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35672747 PMCID: PMC9171744 DOI: 10.1186/s12936-022-04175-w
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 3.469
Fig. 1The complete malaria post network operated by the METF programme in four townships of Karen State, Myanmar. Each point represents a malaria post (coloured by year of opening), operated by a trained malaria post worker delivering free, uninterrupted access to diagnosis and treatment. Coordination of the programme and analysis of data is carried out in Mae Sot, Thailand (black triangle). Map generated using ArcGIS Pro version 2.5
Fig. 2Timeline of the METF programme and surveillance activities. After the commencement of the METF programme in 2014 various targeted surveillance and performance assessments were conducted to maintain and assess the malaria post network performance
Fig. 3Average monthly rate of RDTs and malaria incidence by date and township. Average monthly rapid diagnostic testing rate (RDT—purple line) with 95% confidence intervals (purple area), and average monthly P. falciparum (green line) and P. vivax (orange line) incidence rates at the METF malaria posts
Average monthly incidence of P. falciparum and P. vivax by year and township
| Township | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|
| Hpapun | 13.99 | 7.41 | 3.88 | 3.71 | 3.17 | 0.86 | 0.88 | 1.47 |
| Hlaingbwe | 0.85 | 0.34 | 0.16 | 0.05 | 0.31 | 0.01 | 0.004 | 0.004 |
| Kawkareik | 0.26 | 0.16 | 0.03 | 0.09 | 0.09 | 0.01 | 0.00 | 0.003 |
| Myawaddy | 2.43 | 0.45 | 0.06 | 0.06 | 0.01 | 0.02 | 0.01 | 0.02 |
| Hpapun | 12.81 | 5.80 | 4.60 | 6.81 | 9.78 | 7.93 | 7.07 | 13.01 |
| Hlaingbwe | 4.09 | 1.16 | 0.65 | 0.54 | 1.08 | 0.62 | 0.51 | 2.19 |
| Kawkareik | 0.58 | 0.56 | 0.14 | 0.13 | 0.26 | 0.10 | 0.05 | 0.05 |
| Myawaddy | 8.18 | 6.02 | 3.99 | 4.23 | 4.11 | 3.54 | 5.42 | 7.97 |
Percentage of P. falciparum cases investigated by year and township
| Township | Year of case investigation | ||||
|---|---|---|---|---|---|
| 2017 | 2018 | 2019 | 2020 | 2021† | |
| Hpapun | 0.1 (3/3482) | 0.0 (1/2817) | 4.9 (34/694) | 68.8 (413/600) | 41.2 (310/753) |
| Hlaingbwe | 23.5 (12/51) | 40.5 (66/163) | 91.7 (11/12) | 100 (5/5) | 0.0 (0/0) |
| Kawkareik | 44.4 (4/9) | 81.8 (9/11) | 100.00 (9/8)* | − (0/0) | 100 (1/1) |
| Myawaddy | 57.1 (16/28) | 87.5 (7/8) | 85.7 (6/7) | 75.0 (3/4) | 7.69 (1/13) |
| Total | 1.0 (35/3570) | 2.8 (83/2999) | 8.3 (60/721) | 69.1 (421/609) | 40.6 (312/768) |
† Data collection for 2021 ongoing
* Additional case identified from the field not captured by the weekly data reporting system
Fig. 4Number of A P. falciparum cases investigated, and B monitoring and evaluation visits per malaria post. All individuals diagnosed with P. falciparum that could be contacted were investigated in Hlaingbwe, Kawkareik, and Myawaddy from 2017, and in Hpapun from 2019. Monitoring and evaluation visits were conducted between 2017 and 2021 to assess malaria post performance based on predefined performance indicators. Maps generated using ArcGIS Pro version 2.5
Summary of performance indicators of malaria post functioning recorded during monitoring and evaluation visits by year of monitoring and evaluation visit
| Year of assessment | ||||||
|---|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
| Total visits | 161 | 558 | 447 | 140 | 77 | 7 |
| Malaria post worker absent | 0.0 (0/161) | 1.8 (10/558) | 5.2 (23/447) | 5.0 (7/140) | 1.3 (1/77) | 0.0 (0/7) |
| Malaria post closed for > 24 h in previous 2 months | 22.4 (36/161) | 25.1 (140/558) | 20.1 (90/447) | 10.7 (15/140) | 1.3 (1/77) | 14.3 (1/7) |
| Stock outs for > 2 days in previous 2 months | 6.2 (10/161) | 7.4 (41/551) | 6.6 (28/426) | 8.2 (11/135) | 1.3 (1/76) | 0 (0/7) |
| No validψ RDT onsite | 3.7 (6/161) | 0.9 (5/557) | 8.2 (36/437) | 2.2 (3/139) | 0 (0/77) | 0 (0/7) |
| No validψ ACT onsite | 1.9 (3/161) | 7.9 (44/556) | 5.5 (24/437) | 10.1 (14/139) | 0 (0/77) | 14.3 (1/7) |
| No regular financial support received from METF | 3.7 (6/161) | 2.2 (12/552) | 0.7 (3/429) | 0.0 (0/135) | 0.0 (0/76) | 0.0 (0/7) |
| Number of supervisor visits in previous 2 months | ||||||
| 0 | 19.0 (30/158) | 35.8 (198/553) | 35.5 (154/434) | 57.3 (79/138) | 22.4 (17/76) | 0.0 (0/7) |
| 1 | 18.4 (29/158) | 13.0 (72/553) | 10.1 (44/434) | 6.5 (9/138) | 4.0 (3/76) | 14.3 (1/7) |
| 2–3 | 12.7 (20/158) | 24.4 (135/553) | 17.5 (76/434) | 13.0 (18/138) | 34.2 (26/76) | 57.1 (4/7) |
| ≥ 4 | 50.0 (79/158) | 26.8 (148/553) | 36.9 (160/434) | 23.2 (32/138) | 39.5 (30/76) | 28.6 (2/7) |
| No manual† onsite | 0.6 (1/161) | 3.4 (19/556) | 0.5 (2/444) | 0.0 (0/140) | 0.0 (0/77) | 0.0 (0/7) |
| No reporting forms‡ onsite | 0.6 (1/161) | 1.4 (8/556) | 3.6 (16/444) | 2.1 (3/140) | 0.0 (0/77) | 0.0 (0/7) |
| No logbookξ onsite | 31.7 (51/161) | 52.5 (292/556) | 2.9 (13/444) | 2.1 (3/140) | 0.0 (0/77) | 0.0 (0/7) |
| No record of day of fever | 2.5 (4/161) | 4.0 (22/555) | 5.2 (23/444) | 17.1 (24/140) | 2.6 (2/77) | 0.0 (0/7) |
*Some information could not be collected at every monitoring and evaluation visit resulting in different denominators
ψ Invalid RDTs and artemisinin-based combination medicines are those that were expired or damaged and unusable
†Manual on guidelines for diagnosis and treatment response
‡Reporting forms used to summarize daily data at the end of each week
ξ Logbooks used to record information for each case